Indian drugmakers seized on the patent expiry for Novo Nordisk A/S’s blockbuster weight-loss and diabetes medication to roll out cut-price generic versions in a nation with the third-largest ...

After losing more than 100 pounds following gastric surgery, he tried Ozempic for a while, but the side effects were too much ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...

New research challenges fears about Ozempic weight regain. Cleveland Clinic study of 8,000 patients finds minimal rebound ...

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this ...

It feels like every time you open your phone, another celebrity has a brand-new jawline and a suspiciously tiny waist. We’re ...

Many users of weight loss medicines report hair loss as a side effect, but just how direct is the link between the two? And ...

Zach Reitano discusses scaling GLP-1 care, tackling backlash, and what comes after weight-loss drugs go mainstream.

The comedian and actor, 49, said he took the weight-loss medication for five months ...

GLP-1 medications like Ozempic, Wegovy and Mounjaro have become something of a cultural lightning rod over the past few years ...

Accordingly, GLP-1s have become the Mother’s Little Helper of Dallas real estate agents. “Lots of agents are on them,” ...

One of the hottest classes of drugs in the world owes part of its origin story to a weird desert lizard with a venomous bite ...